| Effect of cholecalciferol on the anticonvulsant action of some second generation antiepileptic drugs in the mouse model of maximal electroshock. | Pharmacol Rep | 2015 Oct | 26398379 |
| The development or exacerbation of eating disorder symptoms after topiramateinitiation. | Pediatrics | 2015 May | 25847809 |
| Drug treatment of obesity: current status and future prospects. | Eur J Intern Med | 2015 Mar | 25634851 |
| Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders. | Psychiatry Res | 2015 Dec 15 | 26455758 |
| Paradoxical topiramate-induced hyperphagia successfully treated with phentermine in a woman with migraine. | J Clin Neurosci | 2015 Aug | 25911503 |
| Safety and tolerability of medications approved for chronic weight management. | Obesity (Silver Spring) | 2015 Apr | 25900872 |
| Topiramate's reduction of body mass index in heavy drinkers: lack of moderationby a GRIK1 polymorphism. | Exp Clin Psychopharmacol | 2014 Oct | 24978347 |
| USL255 extended-release topiramate for the treatment of epilepsy. | Expert Rev Neurother | 2014 Oct | 25220748 |
| Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit. | Clin Cardiol | 2014 Nov | 25223901 |
| Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity. | J Hypertens | 2014 Jun | 24621808 |